Xeris Biopharma Holdings, Inc. (XERS)
7.60
+0.08
(+1.06%)
USD |
NASDAQ |
Jan 20, 16:00
7.69
+0.09
(+1.18%)
After-Hours: 16:47
Xeris Biopharma Holdings Market Cap: 1.261B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.712B |
| Plus Therapeutics, Inc. | 39.47M |
| Assertio Holdings, Inc. | 74.56M |
| NovaBay Pharmaceuticals, Inc. | 825.37M |
| Palatin Technologies, Inc. | 15.06M |
Market Cap Related Metrics
| PS Ratio | 4.559 |
| Price to Free Cash Flow | 121.64 |
| Price | 7.60 |
| Earnings Yield | -1.36% |
| Operating PE Ratio | 123.79 |